Danforth

Activities: Regulatory Finance

Trending Articles

  1. Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain The pharma giant is consolidating parts of its manufacturing network as it advances a $55bn US investment programme aimed at expanding domestic production of advanced medicines
  2. Early phase analytical strategy for biosimilars in a shifting regulatory landscape As FDA and EMA guidance continues to reinforce analytical comparability as the foundation of biosimilar development, investing in comprehensive early-stage characterisation is...
  3. Eli Lilly’s retatrutide hits Phase III goals with FDA filing planned for 2027 Lilly’s triple GIP/GLP-1/glucagon agonist delivered up to 22.6% weight loss in two Phase III trials, with the company now completing its CMC package ahead of a planned US...
  4. Generic drugs to face 100% and 200% tariffs after 2028, says Trump The President said all generic drugs coming into the US will have a tariff rate of 100% after 2028, rising to 200% in 2029 in an effort to reshore drugmaking into America
  5. From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND Join ACG in partnership with Manufacturing Chemist for an expert-led session to explore how different wet granulation methods impact consistency, yield, and quality — and...

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

Related Content

Finance
Danforth Advisors expands to Europe with launch of UK operations

Danforth Advisors expands to Europe with launch of UK operations
Subscribe now